| Trial ID: | L4811 |
| Source ID: | NCT00910923
|
| Associated Drug: |
Jnj-38431055
|
| Title: |
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-38431055 in Healthy Male Volunteers
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: JNJ-38431055
|
| Outcome Measures: |
Primary: To assess the safety and tolerability of JNJ-38431055 | Secondary: To assess the pharmacodynamic effects of JNJ-38431055 on plasma glucose and insulin, during a Meal Tolerance Test (MTT)
|
| Sponsor/Collaborators: |
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
|
| Gender: |
MALE
|
| Age: |
ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
37
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-11
|
| Completion Date: |
2009-04
|
| Results First Posted: |
|
| Last Update Posted: |
2009-10-06
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00910923
|
